To fund the operation, Strategy sold over 1.7 million class A shares for $705.7 million and 621,555 perpetual preferred $STRK shares for $59.7 million. These sales are part of its “42/42” plan, aimed at raising $84 billion in equity and convertible debt to buy bitcoin through 2027. The company still holds nearly $39.8 billion in available class A shares and $STRK for future issuances.

Strategy Sets the Pace for Other Companies
This latest acquisition follows a previous buy of 13,390 $BTC for $1.3 billion earlier in May, pushing the total purchased over the past six months to more than 303,000 bitcoins. The strategy led by founder and executive chairman Michael Saylor continues to set the pace for corporate treasuries adopting bitcoin as a primary reserve asset.

Institutional interest in this model keeps expanding. Japanese investment firm Metaplanet acquired 1,004 bitcoins for $104.3 million, increasing its reserves to 7,800 $BTC. Brazilian fintech Méliuz added 274.5 bitcoins for $28.4 million after securing shareholder approval. Basel Medical Group announced plans to acquire $1 billion in bitcoin, while GD Culture Group and Nakamoto Holdings also unveiled new acquisition programs funded through stock offerings and convertible notes.
Massive Institutional Capital Injection into Bitcoin
Analysts at Bernstein estimate that companies with similar strategies could inject up to $330 billion into bitcoin over the next five years. Although the cryptocurrency’s price remains close to record highs, some analysts warn that the aggressive buying pace could eventually slow down.

Meanwhile, Strategy reported a $4.2 billion net loss in the first quarter, driven by accounting adjustments requiring unrealized losses to be recorded. Even so, the company maintains manageable debt levels, with no significant maturities until 2028.